🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Viewers are urged to contact these profiles privately for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of next-day British shipping. Vendors market the drug there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the United Kingdom is worrisome and could result in individuals administering substances of uncertain source.

Several experts said the popularity for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Response and Material Removal

According to TikTok, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The organization stated it was committed to keeping the platform safe and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also discovered groups with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, filled with images of slimming results, glowing testimonials and detailed instructions for mixing or administering at residence.

Within moments of entering one group, a vendor posted contact information, where most transactions occur. The vendor provided an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.

Item Details and Costs

Within these groups, posts show black plastic packages with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for Telegram said it regularly moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.

Her staff has already encountered individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose users to possibly significant health risks”.